SL Advisors LLC lessened its holdings in shares of The Procter & Gamble Company (NYSE:PG – Free Report) by 6.1% during the 4th quarter, HoldingsChannel reports. The fund owned 2,179 shares of the company’s stock after selling 141 shares during the period. Procter & Gamble accounts for approximately 0.6% of SL Advisors LLC’s portfolio, making the stock its 27th biggest holding. SL Advisors LLC’s holdings in Procter & Gamble were worth $365,000 at the end of the most recent reporting period.
Several other large investors have also recently added to or reduced their stakes in PG. Itau Unibanco Holding S.A. acquired a new position in Procter & Gamble during the second quarter worth $28,000. Fairway Wealth LLC bought a new stake in shares of Procter & Gamble during the 2nd quarter worth $29,000. RPg Family Wealth Advisory LLC acquired a new position in Procter & Gamble in the 3rd quarter valued at $33,000. Quest Partners LLC bought a new position in Procter & Gamble in the 2nd quarter worth $36,000. Finally, Fairfield Financial Advisors LTD bought a new stake in Procter & Gamble during the 2nd quarter valued at approximately $44,000. Institutional investors and hedge funds own 65.77% of the company’s stock.
Procter & Gamble Stock Up 0.1 %
Procter & Gamble stock traded up $0.24 during trading on Wednesday, hitting $161.54. 1,963,319 shares of the company were exchanged, compared to its average volume of 5,939,286. The company has a current ratio of 0.75, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50. The company has a market capitalization of $380.43 billion, a P/E ratio of 27.85, a PEG ratio of 3.70 and a beta of 0.45. The business’s 50 day moving average is $169.92 and its 200 day moving average is $169.75. The Procter & Gamble Company has a 52 week low of $146.28 and a 52 week high of $180.43.
Analyst Upgrades and Downgrades
A number of analysts have weighed in on the stock. Evercore ISI increased their price target on shares of Procter & Gamble from $180.00 to $183.00 and gave the company an “outperform” rating in a report on Monday, October 21st. Hsbc Global Res upgraded shares of Procter & Gamble to a “strong-buy” rating in a research report on Friday, October 4th. JPMorgan Chase & Co. lifted their target price on Procter & Gamble from $179.00 to $186.00 and gave the company an “overweight” rating in a research note on Thursday, September 19th. Barclays downgraded Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price target on the stock. in a research note on Monday, September 30th. Finally, DA Davidson reissued a “buy” rating and issued a $209.00 target price on shares of Procter & Gamble in a research note on Friday, December 27th. Eight investment analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $179.75.
View Our Latest Stock Report on Procter & Gamble
Insider Buying and Selling at Procter & Gamble
In other Procter & Gamble news, CEO R. Alexandra Keith sold 1,992 shares of the company’s stock in a transaction dated Tuesday, October 22nd. The shares were sold at an average price of $170.00, for a total transaction of $338,640.00. Following the completion of the sale, the chief executive officer now directly owns 13,783 shares in the company, valued at $2,343,110. This represents a 12.63 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, insider Balaji Purushothaman sold 12,800 shares of the stock in a transaction dated Thursday, November 21st. The shares were sold at an average price of $172.73, for a total value of $2,210,944.00. Following the sale, the insider now owns 11,595 shares of the company’s stock, valued at $2,002,804.35. This represents a 52.47 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 75,439 shares of company stock worth $13,317,460 over the last ninety days. 0.18% of the stock is currently owned by company insiders.
About Procter & Gamble
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Featured Articles
- Five stocks we like better than Procter & Gamble
- When to Sell a Stock for Profit or Loss
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
- Best Stocks Under $10.00
- Nebius Group (NBIS): A Small-Cap Backed by NVIDIA
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Natural Gas Demand to Surge: Top 3 Stocks and ETFs to Consider
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.